You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CARBINOXAMINE MALEATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for carbinoxamine maleate and what is the scope of patent protection?

Carbinoxamine maleate is the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Endo Operations, Genus, Aytu, Invagen Pharms, Mikart, Mission Pharmacal, Strides Pharma, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has twenty-one patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Eight suppliers are listed for this compound.

Drug Prices for CARBINOXAMINE MALEATE

See drug prices for CARBINOXAMINE MALEATE

Pharmacology for CARBINOXAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for CARBINOXAMINE MALEATE

US Patents and Regulatory Information for CARBINOXAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090417-001 Aug 23, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mcneil CLISTIN carbinoxamine maleate ELIXIR;ORAL 008955-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mission Pharmacal CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090756-001 May 27, 2011 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 040639-002 May 30, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aytu KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CARBINOXAMINE MALEATE

Country Patent Number Title Estimated Expiration
South Korea 101495146 ⤷  Sign Up
Denmark 2018160 ⤷  Sign Up
Denmark 2428205 ⤷  Sign Up
Canada 2645855 FORMULATIONS A LIBERATION MODIFIEE CONTENANT DES COMPLEXES MEDICAMENT - RESINE ECHANGEUSE D'IONS (MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES) ⤷  Sign Up
European Patent Office 2428205 Formulations à libération modifiée contenant des complexes médicament - résine échangeuse d'ions (Modified release formulations containing drug-ion exchange resin complexes) ⤷  Sign Up
Austria E536867 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.